PharmiWeb.com - Global Pharma News & Resources
18-Feb-2022

DOUGLAS GMBH: DOUGLAS GMBH ANNOUNCES SYNDICATION OF €75 MILLION INCREMENTAL TERM LOAN B COMMITMENTS

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL.

Düsseldorf, 18 February 2022. Douglas GmbH (the "Company") announces that it has successfully syndicated incremental term loan B commitments in the amount of €75 million (the "Incremental Term Loan B Commitments"). The Company intends to use the proceeds from the Incremental Term Loan B Commitments to refinance indebtedness incurred by the Douglas group in connection with the Company’s previously announced acquisition of Dutch online pharmacy Disapo.de Apotheke B.V. and future investments in the business of the Douglas group.

* * *This announcement does not constitute an offer to sell or the solicitation of an offer to buy any securities and shall not constitute an offer, solicitation or sale of securities in the United States or in any jurisdiction in which, or to any persons to whom, such offering, solicitation or sale would be unlawful.The distribution of this announcement into certain jurisdictions may be restricted by law. Persons into whose possession this announcement comes should inform themselves about and observe any such restrictions. Any failure to comply with these restrictions may constitute a violation of the laws of any such jurisdiction.

Forward-looking Statements

This news release may include "forward-looking statements" within the meaning of the securities laws of certain applicable jurisdictions. These forward-looking statements include, but are not limited to, all statements other than statements of historical facts contained in this news release, including, without limitation, those regarding the Company's intentions, beliefs or current expectations concerning, among other things: the Company's future financial conditions and performance, results of operations and liquidity; the Company's strategy, plans, objectives, prospects, growth, goals and targets; future developments in the markets in which the Company participates or is seeking to participate; and anticipated regulatory changes in the industry in which the Company operates. These forward-looking statements can be identified by the use of forward-looking terminology, including the terms "anticipate", "believe", "continue", "ongoing", "estimate", "expect", "intend", "may", "plan", "potential", "predict", "project", "target", "seek" or, in each case, their negative, or other variations or comparable terminology. By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors because they relate to events and depend on circumstances that may or may not occur in the future. Past performance is not an indication of future results and past performance should not be taken as a representation that trends or activities underlying past performance will continue in the future. Readers are cautioned that forward-looking statements are not guarantees of future performance and that the Company's actual financial condition, results of operations and cash flows, and the development of the industry in which the Company operates, may differ materially from (and be more negative). The forward-looking statements in this document speak only as at the date of this announcement and the Company and its affiliates expressly disclaim any obligation or undertaking to review or release any updates or revisions to these forward-looking statements to reflect any change in its expectations with regard thereto or any change in events, conditions or circumstances on which any statement is based after the date of this announcement or to update or to keep current any other information contained in this document or to provide any additional information in relation to such forward-looking statements, unless required to do so by applicable law.

ABOUT DOUGLAS

DOUGLAS is the leading premium beauty group in Europe. Offering more than 160,000 beauty and lifestyle products in online shops, the beauty marketplace and around 2,000 stores, DOUGLAS inspires customers to live their own kind of beauty by offering a previously unparalleled assortment. The continued expansion of the fast-growing e-commerce business is the focus of the #FORWARDBEAUTY.DigitalFirst strategy programme. In fiscal year 2020/21, DOUGLAS generated sales of 3.1 billion euros in the areas of perfumery, decorative cosmetics, skin and hair care as well as nutritional supplements, health and accessories.

 

CONTACT

Stefanie Steiner
Head of Investor Relations
Phone: +49 211 16847 8594
Email: ir@douglas.de

 

PRESS CONTACT:
Peter Wübben
Head of Corporate Communications
Phone: +49 211 16847 8569
E-Mail: pr@douglas.de

Editor Details

Last Updated: 18-Feb-2022